MUMBAI Bank of America-Merrill Lynch downgraded its rating on Dr. Reddy's Laboratories Ltd(REDY.NS) to "neutral" from "buy", saying "a slight" increase in core profit estimates was being offset by a fading U.S. drug pipeline and moderating growth.
"We expect multiples to be capped due to modest growth prospects," the investment bank said in an email to clients on Friday.
(Reporting by Abhishek Vishnoi; Editing by Anupama Dwivedi)
Trending On Reuters
Business in india
Thousands of people swarmed the weekend opening of "Make in India" drive to attract foreign direct investment, pitched by PM Modi as "the biggest brand that India has ever created". Full Article | Slideshow